Industry Focus

The Motley Fool's Tyler Crowe, Taylor Muckerman, and Sean O'Reilly discuss a slew of energy sector downgrades by Wall Steet investment banks and why long term investors should just ignore them.

Johnson & Johnson has inked a licensing deal with Achillion Pharmaceuticals that could threaten Gilead Sciences market share in hepatitis C someday. Motley Fool's Michael Douglass and Todd Campbell dig into the details of this deal to see if Gilead Sciences investors should worry.

The Motley Fool’s Sean O’Reilly and Vincent Shen discuss the energy drink market and how the world’s major beverage players are positioning themselves to cash in on this emerging trend.

Technology is revolutionizing the financials space as we know it, from lending to investment advising, and more! 

On today’s edition of Industry Focus, we’ll hear how Facebook is taking iOS to the next level by making news available instantly, without leaving the comfort of your social media page. 

This week we saw two big buys with Noble Energy buying Rosetta Resources and Williams Companies buying out its subsidiary. Is this a signal that the merger and acquisition wave might actually happen? Taylor Muckerman and Tyler Crowe break down these deals and give some insight as to why the merger wave is taking so long and how these deals could shape the future landscape. 

Motley Fool's Michael Douglass and Todd Campbell dig into MannKind Corp.'s first quarter earnings to see if MannKind is a bargain, or a bust.

Motley Fool analysts Vincent Shen and Sean O’Reilly dive into the online travel industry and discuss recent events within the space.

Dividend aristocrats, REITs, red flags, and more – a broad look at dividend investing on today's edition of Industry Focus.

Motley Fool analysts Dylan Lewis and Sean O’Reilly discuss big changes coming to the food delivery industry, with big tech leading the way.

Offshore LNG is officially a thing now! Offshore rigs are getting their groove back, and Big Oil companies should stay out of alternative energy for a reason. Our energy team explains all these things in this week's episode of Industry Focus. 

Alexion Pharmaceuticals is paying $8.4 billion to buy Synageva, a company without any sales, so Fool analyst Michael Douglass and contributor Todd Campbell are digging into this deal to see what it may mean to biotech investors.

Motley Fool analysts Sean O’Reilly and Vincent Shen dive into the data behind the supposed “death of cable”, where things aren’t all what they seem.

Matt Koppenheffer and David Hanson return to the studio to discuss their trip to Omaha.

Motley Fool analysts Dylan Lewis and Sean O’Reilly break down the week in tech earnings, and explain just how Selerity got its hands on Twitter’s earnings and what went wrong for LinkedIn in the first quarter.

Fool Analysts Tyler Crowe and Taylor Muckerman dig into Big Oil's recent earnings results and find some interesting tidbits  about oil prices and why the integrated business model has been successful for so many years in the world of oil. 

Anthem has been a big beneficiary of health insurance reform, so Motley Fool analyst Michael Douglass and contributor Todd Campbell dig into Anthem's first quarter results to see if the ACA continues to drive results higher.

Motley Fool analysts Sean O’Reilly and Dylan Lewis discuss Google’s new cell phone service, “Project Fi” as well as big news from Amazon.

Motley Fool analysts Sean O'Reilly and Vincent Shen discuss why the Comcast / Time Warner Cable merger fell apart and where the industry goes from here.

A 15-minute, 3-step guide to analyzing bank stocks.